Eule CJ - Search Results

1

Time to Next Systemic Therapy After Stereotactic Body Radiation Therapy for Oligoprogressive Metastatic Castrate-Resistant Prostate Cancer.

Eule CJ, Candelario N, Nath SK, Robin TP. Eule CJ, et al. Adv Radiat Oncol. 2024 Oct 20;9(12):101655. doi: 10.1016/j.adro.2024.101655. eCollection 2024 Dec. Adv Radiat Oncol. 2024. PMID: 39620140 Free PMC article.

2

Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer: An Analysis of Real-World Practice Patterns from the CancerLinQ Database.

Eule CJ, Kuna EM, Robin TP, Gershman B, Flaig TW, Kim SP. Eule CJ, et al. Urol Oncol. 2024 Dec;42(12):447.e17-447.e24. doi: 10.1016/j.urolonc.2024.07.002. Epub 2024 Aug 26. Urol Oncol. 2024. PMID: 39191549 Free PMC article.

3

Racial Disparities in Clinical Trial Enrollment Among Patients Diagnosed With Prostate Cancer: A Population-Based Cohort of Oncology Practices.

Wiesen BM, Flaig TW, Gershman B, Konety B, Warren A, Kuna EM, Robin T, Kessler ER, Eule CJ, Breyer BN, Achua J, Kim SP. Wiesen BM, et al. Among authors: eule cj. Adv Urol. 2024 Dec 19;2024:8871425. doi: 10.1155/aiu/8871425. eCollection 2024. Adv Urol. 2024. PMID: 39735345 Free PMC article.

4

Neoadjuvant Cisplatin-based Chemotherapy in Nonmetastatic Muscle-invasive Bladder Cancer: A Systematic Review and Pooled Meta-analysis to Determine the Preferred Regimen.

Eule CJ, Warren A, Molina Kuna E, Callihan EB, Kim SP, Flaig TW. Eule CJ, et al. Urology. 2024 Jun;188:118-124. doi: 10.1016/j.urology.2024.04.034. Epub 2024 Apr 28. Urology. 2024. PMID: 38685388 Free PMC article. Review.

5

Clinical characteristics and treatment of patients with small cell prostate cancer: analysis of a real-world cohort from an oncology database.

Eule CJ, Warren A, Molina Kuna E, Robin TP, Gershman B, Kim SP, Flaig TW. Eule CJ, et al. Prostate Cancer Prostatic Dis. 2024 Nov 21. doi: 10.1038/s41391-024-00914-z. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 39572637

6

Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database.

Eule CJ, Hu J, Hedges D, Jani A, Pshak T, Manley BJ, Sanchez A, Dreicer R, Myint ZW, Zakharia Y, Lam ET. Eule CJ, et al. Cancers (Basel). 2024 May 18;16(10):1920. doi: 10.3390/cancers16101920. Cancers (Basel). 2024. PMID: 38791999 Free PMC article.

7

Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study.

Eule CJ, Hu J, Al-Saad S, Collier K, Boland P, Lewis AR, McKay RR, Narayan V, Bosse D, Mortazavi A, Rose TL, Costello BA, Bryce AH, Lam ET. Eule CJ, et al. Clin Genitourin Cancer. 2023 Aug;21(4):483-490. doi: 10.1016/j.clgc.2023.04.008. Epub 2023 Apr 24. Clin Genitourin Cancer. 2023. PMID: 37193610 Free PMC article.

8

Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterations.

Eule CJ, Flaig TW, Wong K, Graf R, Lam ET. Eule CJ, et al. Prostate Cancer Prostatic Dis. 2023 Mar;26(1):188-193. doi: 10.1038/s41391-022-00612-8. Epub 2022 Nov 19. Prostate Cancer Prostatic Dis. 2023. PMID: 36402814

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters